SEC Form D · filed September 12, 2024
Ensysce Biosciences, Inc
Industry
Other Health Care
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Steve L. Martin · La Jolla, CADirectorCurtis L. Rosebraugh · La Jolla, CADirectorAdam L. Levin · La Jolla, CADirectorWilliam L. Chang · La Jolla, CADirectorAndrew L. Benton · La Jolla, CADirectorLee L. Rauch · La Jolla, CADirectorDavid L. Humphrey · La Jolla, CAExecBob L. Gower · La Jolla, CADirectorChristopher Flynn · Boston, MADirectorJohn Levin · New York, NYDirectorJames Fellows · New York, NYDirectorTelmo Martins · Chicago, ILDirectorSabrina Rusnak-Carlson · Boston, MADirectorMichael Cardamone · NEW YORK, NYDirectorEdward Giordano · New York, NYExecJared Kleinert · NEW YORK, NYDirectorD L. Kirkpatrick · La Jolla, CAExec · DirectorOliver Bell · Road Town, British Virgin IslandsExecPhilip Cater · George Town, Cayman IslandsDirectorThomas Chladek · Baar, V8DirectorAdmire Chatiza · London, United KingdomDirectorJoshua M. Hile · Issaquah, WADirectorJeffrey B. Miller · New Athens, ILDirectorMartin Pawlik · New York, NYDirectorBenjamin Lyons · Raleigh, NCDirectorD L. Kirkpatrick · La Jolla, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗